Toad for Oracle DBA Exadata Edition Renewal
Past New Requirement Updated
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- Total Small Business
Forecast facts
- Anticipated award
- NAICS code
- 541519 Other Computer Related Services
- Points of contact
-
- Justin M Borden justin.borden@nih.gov (301) 480-9887
- Adrian Gutierrez Mora gutierreza@od.nih.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The National Institutes of Health forecasts a new requirement for Toad for Oracle DBA Exadata Edition, with estimated solicitation release and award both on 2026-09-01. The software maintains continuity of operations for the eRA Operations team and supports administration, monitoring, troubleshooting, and performance optimization of the Oracle Exadata environment that underpins mission-critical eRA systems. NIH states that no alternative product can meet its requirements without significant duplication of cost, time, and technical effort, citing the product's established integration, advanced Oracle database management capabilities, and specialized Exadata support.
The estimated award value range is $25,000 to $250,000 under NAICS 541519, Other Computer Related Services, with a Total Small Business set-aside. Points of contact are Justin Borden, Contract Specialist, at justin.borden@nih.gov or +1 301-480-9887, and Adrian Gutierrez Mora, Project Manager for the eRA PMO, at gutierreza@od.nih.gov or +1 301-451-7802.
Forecast text
Toad for Oracle DBA Exadata Edition is required to maintain continuity of operations for the eRA Operations team and support the administration, monitoring, troubleshooting, and performance optimization of the Oracle Exadata environment that underpins mission-critical eRA systems. Due to its established integration within the existing operational environment, advanced Oracle database management capabilities, and specialized Exadata support, no alternative product can meet NIH requirements without significant duplication of cost, time, and technical effort.
Failure to renew would result in reduced operational efficiency, increased administrative burden, diminished troubleshooting and performance tuning capabilities, and substantial costs associated with evaluating, implementing, testing, and validating an alternative solution.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast